Relapse and side effects of steroid therapy beyond 3 years in autoimmune pancreatitis: A multicenter retrospective study
Pancreatology · 2024-03 · 24 (2) · 223-231
DOI: 10.1016/j.pan.2024.01.006 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Pancreatology, 2024-03. Verfasst von Masahiro Tsujimae und 26 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan. Hauptthemen laut MEDLINE: Autoimmune Pancreatitis, Autoimmune Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: JSPS London, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
BACKGROUND: The impact of extended steroid administration on patients with autoimmune pancreatitis after a 3-year maintenance period remains poorly understood. This study analyzed the advantage and disadvantage of continuing steroid therapy beyond 3 years. METHODS: In this retrospective multicenter study across 17 institutions, patients who successfully completed 3 years of maintenance therapy without experiencing relapse were categorized into two groups: the maintenance therapy discontinuation group, who discontinued steroid therapy after the initial 3-year period, and maintenance therapy continuation group, who continued steroid therapy beyond 3 years. The cumulative relapse rate after 3 years of maintenance therapy was the primary outcome. Relapse predictors were compared using the Gray test for cumulative relapse incidence by specific factor. RESULTS: Of 211 patients, 105 experienced no relapse during the 3-year maintenance therapy and were divided into two groups: 69 in the maintenance therapy discontinuation group and 36 in the maintenance therapy continuation group. The relapse rate was lower in the maintenance therapy continuation group than in the maintenance therapy discontinuation group (P = 0.035). Predictors of relapse after 3 years included cessation of maintenance therapy (hazard ratio [HR] = 3.76; 95 % confidence interval [CI] = 1.07-13.3, P = 0.040) and renal involvement (HR = 2.88; 95 % CI = 1.04-7.99, P = 0.042). The maintenance therapy continuation group showed a significantly higher prevalence of macrovascular complications, compared with the maintenance therapy discontinuation group (P = 0.005). CONCLUSIONS: Cessation of steroid maintenance therapy and renal involvement were predictors of relapse after 3 years of maintenance therapy. However, the long-term use of steroids may increase the risk of macrovascular complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan.
- Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan. Electronic address: atmasuda@med.kobe-u.ac.jp.
- Department of Gastroenterology and Hepatology, Osaka Saiseikai Nakatsu Hospital, Osaka, Japan.
- Department of Gastroenterology, Hyogo Prefectural Awaji Medical Center, Sumoto, Japan.
- Division of Gastroenterology and Hepatobiliary and Pancreatic Diseases, Department of Internal Medicine, Hyogo Medical University, Japan.
- Department of Gastroenterology and Hepatology, Yodogawa Christian Hospital, Osaka, Japan.
Förderung
- JSPS London
- Japan Society for the Promotion of Science
Zitieren
APA
Tsujimae, M., Masuda, A., Takagi, M., Kato, T., Nakano, R., Fujita, K., Hirata, Y., Kakuyama, S., Furumatsu, K., Nakagawa, T., Ogisu, K., Fujigaki, S., Iemoto, T., Ezaki, T., Yagi, Y., Ikegawa, T., Yamanaka, K., Sato, Y., Juri, N., …, & KPEC study group (2024). Relapse and side effects of steroid therapy beyond 3 years in autoimmune pancreatitis: A multicenter retrospective study. Pancreatology, 24(2), 223-231. https://doi.org/10.1016/j.pan.2024.01.006
Vancouver
Tsujimae M, Masuda A, Takagi M, Kato T, Nakano R, Fujita K, et al. Relapse and side effects of steroid therapy beyond 3 years in autoimmune pancreatitis: A multicenter retrospective study. Pancreatology. 2024;24(2):223-231. doi:10.1016/j.pan.2024.01.006
BibTeX
@article{Tsujimae2024,
author = {Tsujimae, Masahiro and Masuda, Atsuhiro and Takagi, Megumi and Kato, Takao and Nakano, Ryota and Fujita, Koichi and Hirata, Yuichi and Kakuyama, Saori and Furumatsu, Keisuke and Nakagawa, Takashi and Ogisu, Kyohei and Fujigaki, Seiji and Iemoto, Takao and Ezaki, Takeshi and Yagi, Yosuke and Ikegawa, Takuya and Yamanaka, Kodai and Sato, Yu and Juri, Noriko and Kobayashi, Takashi and Sakai, Arata and Shiomi, Hideyuki and Sanuki, Tsuyoshi and Arisaka, Yoshifumi and Okabe, Yoshihiro and Kodama, Yuzo and KPEC study group, KPEC study group},
title = {Relapse and side effects of steroid therapy beyond 3 years in autoimmune pancreatitis: A multicenter retrospective study},
journal = {Pancreatology},
year = {2024},
volume = {24},
number = {2},
pages = {223--231},
doi = {10.1016/j.pan.2024.01.006}
}
EUVIMED